Jeffrey Modell Foundation: Translational Research Program Grant
Jeffrey Modell Foundation Inc
Funding Amount
Up to US $250,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- The Jeffrey Modell Foundation encourages all international and U.S. investigators with the appropriate knowledge and research skill level to apply for this grant.
- JMF encourages investigators who are not currently receiving funding from the National Institutes of Health to apply.
- Only one active grant per investigator is permitted at a time.
Other requirements
- Novel Primary Immunodeficiency defects.
- Innovative approaches to early diagnosis - Novel therapeutic strategies.
- Translational impact on patient health (i.e., how a patient will benefit)Reach of the proposed project (i.e., how many patients might benefit)Projects that currently do not have funding and would be otherwise difficult to advance without this award.
- Applications submitted by investigators with vast expertise in Primary Immunodeficiency, as well as young investigators with robust scientific merit will be considered.
Overview
The Jeffrey Modell Foundation's Translational Research Program aims to support innovative research in Primary Immunodeficiency. It focuses on advancing clinical applications, improving diagnostic tools, and developing therapies to enhance the quality of life for affected individuals. With over 500 genetic defects identified, this initiative seeks to bridge scientific discoveries and clinical advancements, benefiting millions suffering from these conditions globally. Grants of up to $250,000 over two years are available for impactful projects that lack existing funding.
Note: For application re-submission, please include an updated revision statement. Only one re-submission per application is permitted.
Purpose
To support innovative and novel investigations in Primary Immunodeficiency focusing on translational research leading to meaningful clinical application.
To advance the growing knowledge of genotype-phenotype correlations and gain a better understanding of the underlying mechanisms of immune function and dysfunction.
To support research that will lead to advancement in clinical recognition, diagnostic tools, and innovative therapies that will impact overall health outcomes and improve the quality of life of those affected by Primary Immunodeficiency.
It is estimated that as many as 10 million people, if not more, are living with Primary Immunodeficiency worldwide. As such, it is crucial to support research that will bridge basic scientific discoveries to the development of clinical applications that will impact overall health outcomes. Advancing research that enhances our understanding of the immune system represents one of the single greatest strategies that biomedical science has to offer to identify new therapies and will greatly benefit those living with diagnosed Primary Immunodeficiencies as well as the millions of people that remain undiagnosed.
Award Information
The number of awards per cycle will be dependent on the strength and merit of applications received and the availability of funds. Individual awards may total up to $250,000 over a two-year period. Funds are not to exceed $125,000 per year per project. Total funds will only support direct costs and cannot be used for institutional overhead. JMF reserves the right to reduce the award amount for any application. To date, a total of 23 grants have been awarded throughout 12 grant cycles.
Eligibility
Novel Primary Immunodeficiency defectsInnovative approaches to early diagnosis - Novel therapeutic strategiesTranslational impact on patient health (i.e., how a patient will benefit)Reach of the proposed project (i.e., how many patients might benefit)Projects that currently do not have funding and would be otherwise difficult to advance without this awardThe Jeffrey Modell Foundation encourages all international and U.S. investigators with the appropriate knowledge and research skill level to apply for this grant. Applications submitted by investigators with vast expertise in Primary Immunodeficiency, as well as young investigators with robust scientific merit will be considered. JMF encourages investigators who are not currently receiving funding from the National Institutes of Health to apply. Only one active grant per investigator is permitted at a time.
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
NRL Long Range Broad Agency Announcement (BAA) for Basic and Applied Research
Naval Research Laboratory
Amount
Varies
Deadline
December 30, 2026
Cultural Anthropology Program Senior Research Awards (CA-SR)
U.S. National Science Foundation
Amount
$4,000,000 total
Deadline
January 15, 2027
Bronchoscopy Research Grant
Intuitive Foundation
Amount
Up to US $75,000
Deadline
January 4, 2027
Listed date — confirm with the funder
IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
National Institutes of Health
Amount
$1,200,000 total
Deadline
December 14, 2026
Boosting Innovative GEOINT - Science & Technology Broad Agency Announcement (BIG-ST BAA)
National Geospatial-Intelligence Agency
Amount
Varies
Deadline
December 14, 2026
Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)
National Institutes of Health
Amount
$5,000,000 total
Deadline
December 14, 2026
Ready to apply for Jeffrey Modell Foundation: Translational Research Program Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Jeffrey Modell Foundation: Translational Research Program Grant. Now let's win it.